Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Estrogen affects how vitamin A is processed in mouse skin, which may impact acne treatment, hair growth, and skin defense.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

MK-386 reduces sebum DHT levels.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

New compounds show promise as nonsteroidal treatments for hair loss.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Ruxolitinib treatment may cause eyelash growth.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

15-lipoxygenase helps keep skin healthy by reducing inflammation.

Bone mineral and minocycline boost bone cell growth, aiding healing.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Tofacitinib was more effective than methotrexate for treating alopecia areata.